Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Neil Kumar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer E. Cook - $21.92M of BBIO open-market activity in the last 12 months
- Frank McCormick - $17.25M of BBIO open-market activity in the last 12 months
- Andrew Lo - $6.32M of BBIO open-market activity in the last 12 months
- Andrea Ellis - $5.65M of BBIO open-market activity in the last 12 months
- Hannah Valantine - $4.37M of BBIO open-market activity in the last 12 months
- Ronald J. Daniels - $3.89M of BBIO open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Neil Kumar?
Neil Kumar is a corporate insider, tracked as Chief Executive Officer, Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha holds 28 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Neil Kumar submitted recently?
4 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Neil Kumar been buying or selling stock?
Recorded transactions: 0 open-market purchases and 122 open-market sales ($62.04M) across all tracked filings.
Where can I see all of Neil Kumar's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Neil Kumar and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
